Drug Type Small molecule drug, Fluorescent dyes |
Synonyms Altafluor benox |
Target |
Mechanism SCNA modulators(Sodium channel alpha subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (14 Dec 2017), |
Regulation- |
Molecular FormulaC20H12NaO5 |
InChIKeyKHBIARCXLUWABL-UHFFFAOYSA-N |
CAS Registry518-47-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | US | 09 Mar 2020 | |
Ophthalmologic surgical procedures | US | 14 Dec 2017 |
Phase 3 | 507 | (Brimonidine Tartrate) | tmwppcvwsq(gkoihmiact) = rkdzzggmqr arbhddvbrm (tytgyupbzq, wbaznbhlji - aiuiwdwjtk) View more | - | 23 Oct 2019 | ||
(Brimonidine Tartrate Vehicle) | tmwppcvwsq(gkoihmiact) = hrsbwutlxd arbhddvbrm (tytgyupbzq, celyberghg - ojwxrfpycj) View more | ||||||
Phase 3 | 60 | (Brimonidine Tartrate) | bhmlsoavif(rdbgbsixak) = fwijturdro acvryhfegs (jsjgojpgsg, xflqauhyxz - djtijolqqm) View more | - | 23 Oct 2019 | ||
(Brimonidine Tartrate Vehicle) | bhmlsoavif(rdbgbsixak) = mahioloehg acvryhfegs (jsjgojpgsg, pjqltwioml - vgzbgwaros) View more |